Trial NCT04611139

View at ClinicalTrials.gov 
Org. Study IDs: HRI-SP-2577-001

Last trial update was posted on 2022-03-02

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Endometrioid Endometrial Neoplasms

Other Conditions

Endometrial Cancer Ovarian Clear Cell Tumor Ovarian Endometrioid Adenocarcinoma SCCOHT

Stopping Reasons

Salarius discontinued support

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID